Life Sciences

Life Sciences Law360 provides breaking legal news and analysis on the pharmaceutical and medical device industry. Coverage includes high-stakes litigation and policy developments that affect life sciences companies, as well as licensing deals, mergers, and other corporate transactions.



Sign up for a 7-day FREE trial today!



Latest News in Life Sciences

  • November 10, 2026

    Costco Can't End Dog Food Heart Risk Suit Yet, Buyers Say

    Dog owners on Monday told a Washington federal judge that Costco's bid to dismiss their proposed class action alleging that its grain-free dog food contributes to canine heart disease ignores their factual allegations, saying that the company is cherry-picking from studies about the risk.

  • November 10, 2026

    Pharma Co. Investors Ink $4M Deal In FDA Hurdle Suit

    Verrica Pharmaceuticals and a group of investors have reached a $4 million deal to end claims that the company hid obstacles it faced in obtaining U.S. Food and Drug Administration approval for its lead product.

  • November 10, 2026

    LA Cannabis Retailer Sued Over Email 'Spy Pixels'

    A Los Angeles dispensary placed "malicious" code in marketing emails that spied on a consumer and recorded when she opened the messages and her location, forwarding the information to data-broker vendors, according to a California state lawsuit which seeks $1,000 per email and $5,000 per privacy violation.

  • November 10, 2026

    Idaho Judge Stays Abortion Relief, Citing 9th Circ. Ruling

    An Idaho federal judge on Tuesday stayed his finding that the state would violate the 14th Amendment by criminalizing certain abortions performed by a doctor challenging the state's abortion laws, saying he is bound by a Ninth Circuit decision he "strongly disagrees" with.

  • November 10, 2026

    Drugmaker Inks $2.5M Deal In Failed Weight Loss Drug Suit

    Drugmaker Skye Bioscience Inc. has reached a $2.5 million settlement with investors that would end a proposed securities class action alleging the company overhyped a weight-loss drug, causing its stock price to plummet once the truth came to light.

See more Life Sciences news

Life Sciences

Areas of Coverage

  • AGENCIES
  • U.S. Consumer Product Safety Commission
  • U.S. Food and Drug Administration
  • U.S. Patent and Trademark Office
  • U.S. International Trade Commission
  • POLICY & REGULATION
  • Affordable Care Act
  • Federal Food, Drug, and Cosmetic Act
  • Antitrust and consumer protection controls
  • Drug and medical device lobbying
  • State and international life sciences legislation and regulation
  • ENFORCEMENT
  • Drug and medical device recalls
  • Drug safety actions
  • Pay-for-delay investigations
  • Merger reviews
  • LITIGATION
  • Patent disputes, including
  • Abbreviated New Drug Application litigation
  • Section 301 cases
  • Product safety suits over drugs and medical devices, including off-label marketing and failure-to-warn claims
  • Consumer litigation and class actions
  • Fraud and compliance suits
  • Antitrust disputes
  • Labor and employment suits
  • Shareholder and corporate governance disputes
  • Bankruptcy proceedings
  • TRANSACTIONS
  • Mergers, acquisitions, and joint ventures
  • Share buybacks and stock splits
  • Private equity deals
  • Patent-licensing agreements
  • PROFILES
  • Personnel moves
  • Profiles of life sciences practice groups

Readership

  • Life sciences lawyers at top law firms
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Executives and attorneys in the drug, biotechnology, and medical device industries
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals